Epic Ventures Gains $200M Fresh Capital
August 28, 2025
Epic Ventures has received $200M of fresh capital to support early-stage founders solving meaningful problems in healthcare, software, AI, and beyond. The fund is positioned as a strategic public and private initiative to back the region’s best entrepreneurs and attract collaboration between the top innovators in the world and the principal economic centers of the Intermountain West. The company will be investing locally and globally.
Recent News
- 2026 Life Sciences Awards to be Presented at the Mayer Brown Utah Life Sciences Summit
- PROGRESS TRIAL DEMONSTRATES EDWARDS TAVR IS SUPERIOR TO CLINICAL SURVEILLANCE FOR MODERATE AS PATIENTS WITH AT-RISK FEATURES
- Denali Therapeutics Receives 2026 Prix Galien USA Award for AVLAYAH® (tividenofusp alfa-eknm) as Best Biotechnology Product
- Utah Business, Government Leaders Deepen Connections in Ireland
- Co-Diagnostics’ Joint Venture CoSara Diagnostics Announces Publication of Peer-Reviewed HPV Screening Study Using CoSara’s SARAGENE® Test
- Merit Medical Acquires Solo Pace, Inc., Expanding Its Cardiac Therapies Platform with Innovative TAVR Pacing Technology
